Business Context and Reporting Period
Company: The Estée Lauder Companies Inc.
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: September 30, 2009 (First Quarter of Fiscal 2010)
Business Overview: The Company is a worldwide manufacturer, marketer, and distributor of skin care, makeup, fragrance, and hair care products. Operations are conducted across three geographic regions: The Americas, Europe/Middle East/Africa, and Asia/Pacific.
Key Financial Metrics
| Metric (in millions) | Q1 2010 (Sep 30, 2009) | Q1 2009 (Sep 30, 2008) |
|---|---|---|
| Net Sales | $1,833.4 | $1,903.5 |
| Gross Profit | $1,388.3 | $1,403.4 |
| Gross Margin | 75.7% | 73.7% |
| Operating Income | $220.4 | $92.5 |
| Operating Margin | 12.0% | 4.8% |
| Net Earnings (Attributable to Company) | $140.7 | $51.1 |
| Diluted EPS | $0.71 | $0.26 |
| Cash and Cash Equivalents | $799.2 | $328.8 |
| Total Debt | $1,408.9 | Filing text does not provide clear total debt for Q1 2008 |
| Operating Cash Flow | $2.7 | ($196.2) |
Material Changes vs. Prior Period
- Revenue: Net sales decreased 4% ($70.1 million) primarily due to declines in The Americas and Europe/Middle East/Africa regions, partially offset by an 11% increase in Asia/Pacific. Foreign currency translation negatively impacted sales by approximately $54.3 million.
- Profitability: Operating income increased 138% ($127.9 million) and Net Earnings increased 175% ($89.6 million). This significant improvement was driven by aggressive cost containment, lower operating expenses (63.7% of sales vs. 68.9% prior year), and improved gross margins, despite lower sales volumes.
- Restructuring Charges: The Company recorded $42.3 million in total charges associated with restructuring activities in the current quarter, compared to $0.1 million in the prior year. This includes $18.5 million for anticipated sales returns and inventory write-offs related to exiting the Prescriptives brand wholesale distribution.
- Cash Flow: Operating cash flow turned positive ($2.7 million) compared to a significant outflow ($196.2 million) in the prior year, attributed to higher net earnings and lower inventory levels.
Guidance, Outlook, and Risks
- Restructuring Program: The Company is implementing a multi-faceted cost savings program announced in February 2009. Total expected charges are between $350 million and $450 million before taxes, with anticipated savings of $450 million to $550 million.
- Outlook: Management remains cautious regarding the duration of the global economic downturn and the potential impact of the H1N1 virus. While results exceeded original net sales expectations, the Company expects to accelerate investment spending in the remainder of the fiscal year.
- Risks: Key risks include continued retailer destocking, tighter working capital management by customers, foreign currency fluctuations (strengthening U.S. dollar), and the financial strength of retail customers.
- Legal Contingencies: The Company is involved in litigation regarding the Blydenburgh landfill in New York. Management believes the resolution will not have a material adverse effect, and an accrual has been made for the Company's share.
Investor Verification Checklist
- Restructuring Impact: Verify the execution of the $350-$450 million restructuring program and the specific impact of exiting the Prescriptives brand wholesale distribution on future revenue streams.
- Regional Performance: Monitor the divergence between the declining Americas/Europe markets and the growing Asia/Pacific market to assess long-term geographic strategy.
- Currency Exposure: Assess the sensitivity of future earnings to foreign exchange rates, given the significant negative translation impact ($54.3 million) in the current quarter.
- Inventory Levels: Review inventory turnover and levels, as the Company cited lower inventory as a driver for improved operating cash flow.
- Debt Covenants: Confirm continued compliance with the interest expense coverage ratio covenant (currently 11:1) on the $750 million revolving credit facility.